Junhyuk Kang

Seungho Lee School of Chemical Engineering and Applied Chemistry, Kyungpook National University, Daehak-ro 80, Buk-gu, Daegu, 41566 Republic of Korea School of Chemical, Biological and Battery Engineering, Gachon University, Seongnam-si, Gyeonggi-do, 13120 Republic of Korea Search for more papers by this author

MAIN TEXT This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/aor.14467 Abstract Background Continuous-flow ventricular assist devices (cfVADs) are implanted in patients with end-stage heart failure to assist with blood circulation.